Purchase online company lists of companies

Company Summary

Human Genome Sciences, Inc. is a biopharmaceutical company with a pipeline of compounds in clinical development, including drugs to treat such diseases as hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and human immunodeficiency virus/acquired immunodeficiency syndrome (Hiv/ Aids). Human Genome Sciences has an active preclinical development program, including human protein and antibody drugs discovered through genomics-based research, and new long-acting versions of existing proteins created using its albumin fusion technology. All but one of the Company's drugs that are in clinical trials is derived from genomics-based research. As of December 31, 2005, its drugs in clinical development are Albuferon; Lymphostat-B; Abthrax ; Hgs-Etr; Hgs-Etr2 and Hgs-Tr2j, and Ccr5 mab. The other drug in clinical trials is an albumin fusion protein.
Human Genome Sciences, Inc. specializes in the application of science and great medicine to bring innovative drugs to patients with unmet medical needs. The company produce and purify multiple protein and antibody drugs in two state-of-the-art process development and manufacturing facilities.

General Information

  • Year established

    1996

  • Type of company

    Head Office

  • Fax

    +1 301 309-8512 (FPS)

  • Website

    http://www.hgsi.com

Key figures

Employees

  • Company

    500-999 Employees

Turnover

  • 2007

    25 to 50 million USD

Executives

Executive information

  • H. Thomas Watkins

    Chief Executive Officer

  • T. B.

    Chief Financial Officer

  • A. K.

    Chairman Emeritus

  • A. E.

    Controller

  • B. L.

    Exec. Vice President

  • W. A. H.

    Chairman of the Board, Chief Executive Officer

  • S. C. M.

    Chief Financial Officer, Senior Vice President

  • C. A. R.

    Executive Vice President of Research and Development, Director

  • J. H. D.

    Senior Vice President, General Counsel and Secretary

  • S. B.

    Senior Vice President of Human Resources

  • P. K.

    Senior Vice President, Business Development

  • A. B.

    Manager

  • A. W.

    Vice President - Clinical Operations

  • A. L.

    Chair of the Compensation Committee

  • B. L.

    Executive Vice President and Chief Commercial Officer

  • C. S.

    Senior Vice President - Operations

  • D. O.

    Vice President, Clinical Research � General Medicine

  • D. S.

    Executive Vice President and Chief Financial Officer

  • D. D.

    Vice President - Regulatory Affairs

  • J. P.

    Vice President

Activities

Activities

  • Producer
  • Distributor
  • Service provider

Other classifications (for some countries)

SIC (US 1987) :
Pharmaceutical preparations (2834)
SIC (US 1987) :
Commercial physical research (8731)
NAICS (US 2012) :
Pharmaceutical Preparation Manufacturing (325412)
NAICS (US 2012) :
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology) (541712)

You might also like

You might also like:

Our business solutions

  • With Kompass :
  • Global presence in more than 60 countries
  • Detailed and up to date company information
  • Comprehensive and filtered company directory